Form 4 Filing for Milestone Pharmaceuticals Inc.

Joseph Oliveto, President and CEO of Milestone Pharmaceuticals Inc. (MIST), reported the sale of 36,500 common shares on April 16, 2026. The shares were sold at a weighted average price of $2.26 per share, with transactions ranging from $2.25 to $2.28. This sale was conducted under a Rule 10b5-1 trading plan adopted on September 30, 2025. Following the transaction, Oliveto holds 446,244 shares. The filing is a Form 4, indicating a change in beneficial ownership.